nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenelzine—CYP3A43—Dexamethasone—psoriasis	0.116	0.152	CbGbCtD
Phenelzine—CYP2C8—Tazarotene—psoriasis	0.0659	0.0864	CbGbCtD
Phenelzine—CYP3A5—Beclomethasone—psoriasis	0.0637	0.0836	CbGbCtD
Phenelzine—CYP2C8—Cholecalciferol—psoriasis	0.0281	0.0369	CbGbCtD
Phenelzine—CYP3A7—Hydrocortisone—psoriasis	0.0272	0.0356	CbGbCtD
Phenelzine—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0272	0.0356	CbGbCtD
Phenelzine—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0256	0.0336	CbGbCtD
Phenelzine—CYP3A7—Cyclosporine—psoriasis	0.0256	0.0336	CbGbCtD
Phenelzine—CYP3A5—Mycophenolate mofetil—psoriasis	0.0254	0.0333	CbGbCtD
Phenelzine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0244	0.032	CbGbCtD
Phenelzine—CYP2C19—Cholecalciferol—psoriasis	0.0236	0.0309	CbGbCtD
Phenelzine—CYP3A4—Calcitriol—psoriasis	0.0222	0.029	CbGbCtD
Phenelzine—CYP3A5—Hydrocortisone—psoriasis	0.0204	0.0267	CbGbCtD
Phenelzine—CYP2C8—Hydrocortisone—psoriasis	0.0196	0.0257	CbGbCtD
Phenelzine—CYP3A5—Cyclosporine—psoriasis	0.0192	0.0252	CbGbCtD
Phenelzine—CYP2C8—Cyclosporine—psoriasis	0.0185	0.0242	CbGbCtD
Phenelzine—CYP3A4—Methoxsalen—psoriasis	0.0172	0.0226	CbGbCtD
Phenelzine—CYP3A7—Dexamethasone—psoriasis	0.0169	0.0221	CbGbCtD
Phenelzine—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0169	0.0221	CbGbCtD
Phenelzine—CYP2C19—Prednisone—psoriasis	0.0164	0.0215	CbGbCtD
Phenelzine—CYP2E1—Dexamethasone—psoriasis	0.0163	0.0214	CbGbCtD
Phenelzine—CYP2C19—Cyclosporine—psoriasis	0.0155	0.0203	CbGbCtD
Phenelzine—CYP3A5—Dexamethasone—psoriasis	0.0127	0.0166	CbGbCtD
Phenelzine—CYP2C8—Dexamethasone—psoriasis	0.0122	0.016	CbGbCtD
Phenelzine—CYP3A4—Cholecalciferol—psoriasis	0.0114	0.015	CbGbCtD
Phenelzine—CYP2C19—Dexamethasone—psoriasis	0.0102	0.0134	CbGbCtD
Phenelzine—CYP3A4—Triamcinolone—psoriasis	0.0099	0.013	CbGbCtD
Phenelzine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0099	0.013	CbGbCtD
Phenelzine—CYP3A4—Betamethasone—psoriasis	0.00849	0.0111	CbGbCtD
Phenelzine—CYP3A4—Prednisolone—psoriasis	0.00838	0.011	CbGbCtD
Phenelzine—CYP3A4—Hydrocortisone—psoriasis	0.00794	0.0104	CbGbCtD
Phenelzine—CYP3A4—Prednisone—psoriasis	0.00791	0.0104	CbGbCtD
Phenelzine—CYP3A4—Cyclosporine—psoriasis	0.0075	0.00983	CbGbCtD
Phenelzine—CYP3A43—Miscellaneous substrates—CYP2S1—psoriasis	0.00716	0.128	CbGpPWpGaD
Phenelzine—CYP3A4—Dexamethasone—psoriasis	0.00494	0.00647	CbGbCtD
Phenelzine—CYP3A43—Xenobiotics—CYP2S1—psoriasis	0.00476	0.0849	CbGpPWpGaD
Phenelzine—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00224	0.0399	CbGpPWpGaD
Phenelzine—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00198	0.0352	CbGpPWpGaD
Phenelzine—CYP3A43—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00195	0.0348	CbGpPWpGaD
Phenelzine—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00194	0.0345	CbGpPWpGaD
Phenelzine—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.00192	0.0342	CbGpPWpGaD
Phenelzine—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00173	0.0308	CbGpPWpGaD
Phenelzine—CYP3A43—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.0016	0.0286	CbGpPWpGaD
Phenelzine—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00139	0.0248	CbGpPWpGaD
Phenelzine—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.00139	0.0247	CbGpPWpGaD
Phenelzine—MAOB—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00121	0.0217	CbGpPWpGaD
Phenelzine—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.0012	0.0214	CbGpPWpGaD
Phenelzine—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00107	0.0191	CbGpPWpGaD
Phenelzine—CYP3A43—Biological oxidations—CYP2S1—psoriasis	0.000851	0.0152	CbGpPWpGaD
Phenelzine—CYP3A43—Metapathway biotransformation—CYP2S1—psoriasis	0.00084	0.015	CbGpPWpGaD
Phenelzine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000796	0.0142	CbGpPWpGaD
Phenelzine—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000786	0.014	CbGpPWpGaD
Phenelzine—MAOA—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000762	0.0136	CbGpPWpGaD
Phenelzine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000646	0.0115	CbGpPWpGaD
Phenelzine—MAOB—Biological oxidations—CYP2S1—psoriasis	0.000645	0.0115	CbGpPWpGaD
Phenelzine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000644	0.0115	CbGpPWpGaD
Phenelzine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000577	0.0103	CbGpPWpGaD
Phenelzine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000576	0.0103	CbGpPWpGaD
Phenelzine—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000569	0.0101	CbGpPWpGaD
Phenelzine—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000568	0.0101	CbGpPWpGaD
Phenelzine—MAOB—Tryptophan metabolism—CAT—psoriasis	0.000557	0.00992	CbGpPWpGaD
Phenelzine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000499	0.00889	CbGpPWpGaD
Phenelzine—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000492	0.00877	CbGpPWpGaD
Phenelzine—MAOA—Oxidative Stress—CAT—psoriasis	0.000492	0.00876	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—NDUFA5—psoriasis	0.000483	0.0086	CbGpPWpGaD
Phenelzine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000468	0.00833	CbGpPWpGaD
Phenelzine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000467	0.00832	CbGpPWpGaD
Phenelzine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000445	0.00793	CbGpPWpGaD
Phenelzine—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000439	0.00783	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—CYP2S1—psoriasis	0.00041	0.00731	CbGpPWpGaD
Phenelzine—MAOA—Biological oxidations—CYP2S1—psoriasis	0.000405	0.00722	CbGpPWpGaD
Phenelzine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000404	0.0072	CbGpPWpGaD
Phenelzine—GPT—Metabolism—NDUFA5—psoriasis	0.000393	0.00701	CbGpPWpGaD
Phenelzine—MAOA—Melatonin metabolism and effects—APOE—psoriasis	0.000393	0.007	CbGpPWpGaD
Phenelzine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000361	0.00643	CbGpPWpGaD
Phenelzine—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000343	0.00611	CbGpPWpGaD
Phenelzine—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000338	0.00603	CbGpPWpGaD
Phenelzine—GPT—Metabolism—CYP2S1—psoriasis	0.000334	0.00596	CbGpPWpGaD
Phenelzine—Tremor—Cyclosporine—psoriasis	0.000291	0.00161	CcSEcCtD
Phenelzine—Ill-defined disorder—Cyclosporine—psoriasis	0.000289	0.00159	CcSEcCtD
Phenelzine—Agitation—Cyclosporine—psoriasis	0.000286	0.00158	CcSEcCtD
Phenelzine—Tremor—Mycophenolate mofetil—psoriasis	0.000284	0.00157	CcSEcCtD
Phenelzine—Insomnia—Mycophenolic acid—psoriasis	0.000284	0.00157	CcSEcCtD
Phenelzine—Nausea—Acitretin—psoriasis	0.000284	0.00157	CcSEcCtD
Phenelzine—Nausea—Fluocinolone Acetonide—psoriasis	0.000283	0.00156	CcSEcCtD
Phenelzine—Paraesthesia—Mycophenolic acid—psoriasis	0.000282	0.00156	CcSEcCtD
Phenelzine—Ill-defined disorder—Mycophenolate mofetil—psoriasis	0.000282	0.00156	CcSEcCtD
Phenelzine—Malaise—Cyclosporine—psoriasis	0.000281	0.00155	CcSEcCtD
Phenelzine—Somnolence—Mycophenolic acid—psoriasis	0.000279	0.00154	CcSEcCtD
Phenelzine—Agitation—Mycophenolate mofetil—psoriasis	0.000279	0.00154	CcSEcCtD
Phenelzine—Leukopenia—Cyclosporine—psoriasis	0.000278	0.00154	CcSEcCtD
Phenelzine—Dyspepsia—Mycophenolic acid—psoriasis	0.000276	0.00153	CcSEcCtD
Phenelzine—Malaise—Mycophenolate mofetil—psoriasis	0.000274	0.00151	CcSEcCtD
Phenelzine—Erectile dysfunction—Prednisone—psoriasis	0.000272	0.0015	CcSEcCtD
Phenelzine—Leukopenia—Mycophenolate mofetil—psoriasis	0.000272	0.0015	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000271	0.0015	CcSEcCtD
Phenelzine—Fatigue—Mycophenolic acid—psoriasis	0.000271	0.0015	CcSEcCtD
Phenelzine—Convulsion—Cyclosporine—psoriasis	0.00027	0.00149	CcSEcCtD
Phenelzine—Asthenia—Hydroxyurea—psoriasis	0.000269	0.00149	CcSEcCtD
Phenelzine—Weight increased—Prednisone—psoriasis	0.000269	0.00148	CcSEcCtD
Phenelzine—Ataxia—Methotrexate—psoriasis	0.000268	0.00148	CcSEcCtD
Phenelzine—Constipation—Mycophenolic acid—psoriasis	0.000268	0.00148	CcSEcCtD
Phenelzine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000268	0.00477	CbGpPWpGaD
Phenelzine—Vision blurred—Prednisolone—psoriasis	0.000267	0.00147	CcSEcCtD
Phenelzine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000265	0.00472	CbGpPWpGaD
Phenelzine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000264	0.00471	CbGpPWpGaD
Phenelzine—Anxiety—Cyclosporine—psoriasis	0.000264	0.00146	CcSEcCtD
Phenelzine—Convulsion—Mycophenolate mofetil—psoriasis	0.000263	0.00145	CcSEcCtD
Phenelzine—Ill-defined disorder—Prednisolone—psoriasis	0.000263	0.00145	CcSEcCtD
Phenelzine—Discomfort—Cyclosporine—psoriasis	0.000262	0.00145	CcSEcCtD
Phenelzine—Dry mouth—Cyclosporine—psoriasis	0.000259	0.00143	CcSEcCtD
Phenelzine—Feeling abnormal—Mycophenolic acid—psoriasis	0.000259	0.00143	CcSEcCtD
Phenelzine—Anxiety—Mycophenolate mofetil—psoriasis	0.000257	0.00142	CcSEcCtD
Phenelzine—Ill-defined disorder—Hydrocortisone—psoriasis	0.000257	0.00142	CcSEcCtD
Phenelzine—Malaise—Prednisolone—psoriasis	0.000255	0.00141	CcSEcCtD
Phenelzine—Discomfort—Mycophenolate mofetil—psoriasis	0.000255	0.00141	CcSEcCtD
Phenelzine—Oedema—Cyclosporine—psoriasis	0.000254	0.0014	CcSEcCtD
Phenelzine—Dry mouth—Mycophenolate mofetil—psoriasis	0.000253	0.0014	CcSEcCtD
Phenelzine—MAOA—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000251	0.00448	CbGpPWpGaD
Phenelzine—Malaise—Hydrocortisone—psoriasis	0.000249	0.00138	CcSEcCtD
Phenelzine—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000248	0.00443	CbGpPWpGaD
Phenelzine—Body temperature increased—Mycophenolic acid—psoriasis	0.000248	0.00137	CcSEcCtD
Phenelzine—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000248	0.00442	CbGpPWpGaD
Phenelzine—Dizziness—Hydroxyurea—psoriasis	0.000248	0.00137	CcSEcCtD
Phenelzine—Oedema—Mycophenolate mofetil—psoriasis	0.000248	0.00137	CcSEcCtD
Phenelzine—Hyperhidrosis—Cyclosporine—psoriasis	0.000245	0.00136	CcSEcCtD
Phenelzine—Convulsion—Prednisolone—psoriasis	0.000245	0.00136	CcSEcCtD
Phenelzine—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000245	0.00437	CbGpPWpGaD
Phenelzine—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000244	0.00436	CbGpPWpGaD
Phenelzine—Shock—Mycophenolate mofetil—psoriasis	0.000244	0.00135	CcSEcCtD
Phenelzine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000242	0.00134	CcSEcCtD
Phenelzine—Ill-defined disorder—Triamcinolone—psoriasis	0.000242	0.00133	CcSEcCtD
Phenelzine—Convulsion—Hydrocortisone—psoriasis	0.00024	0.00132	CcSEcCtD
Phenelzine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000239	0.00132	CcSEcCtD
Phenelzine—Vomiting—Hydroxyurea—psoriasis	0.000238	0.00132	CcSEcCtD
Phenelzine—Discomfort—Prednisolone—psoriasis	0.000238	0.00132	CcSEcCtD
Phenelzine—Rash—Hydroxyurea—psoriasis	0.000236	0.00131	CcSEcCtD
Phenelzine—Dermatitis—Hydroxyurea—psoriasis	0.000236	0.0013	CcSEcCtD
Phenelzine—Malaise—Triamcinolone—psoriasis	0.000235	0.0013	CcSEcCtD
Phenelzine—Headache—Hydroxyurea—psoriasis	0.000235	0.0013	CcSEcCtD
Phenelzine—Anxiety—Hydrocortisone—psoriasis	0.000235	0.0013	CcSEcCtD
Phenelzine—MAOA—Melatonin metabolism and effects—NFKB1—psoriasis	0.000233	0.00416	CbGpPWpGaD
Phenelzine—Discomfort—Hydrocortisone—psoriasis	0.000233	0.00129	CcSEcCtD
Phenelzine—Oedema—Prednisolone—psoriasis	0.000231	0.00128	CcSEcCtD
Phenelzine—Insomnia—Cyclosporine—psoriasis	0.00023	0.00127	CcSEcCtD
Phenelzine—Paraesthesia—Cyclosporine—psoriasis	0.000228	0.00126	CcSEcCtD
Phenelzine—Shock—Prednisolone—psoriasis	0.000227	0.00126	CcSEcCtD
Phenelzine—Erectile dysfunction—Methotrexate—psoriasis	0.000227	0.00126	CcSEcCtD
Phenelzine—MAOA—Oxidative Stress—NFKB1—psoriasis	0.000227	0.00405	CbGpPWpGaD
Phenelzine—Somnolence—Cyclosporine—psoriasis	0.000226	0.00125	CcSEcCtD
Phenelzine—Oedema—Hydrocortisone—psoriasis	0.000226	0.00125	CcSEcCtD
Phenelzine—Convulsion—Triamcinolone—psoriasis	0.000226	0.00125	CcSEcCtD
Phenelzine—Tachycardia—Prednisolone—psoriasis	0.000226	0.00125	CcSEcCtD
Phenelzine—Asthenia—Mycophenolic acid—psoriasis	0.000225	0.00124	CcSEcCtD
Phenelzine—Insomnia—Mycophenolate mofetil—psoriasis	0.000224	0.00124	CcSEcCtD
Phenelzine—Dyspepsia—Cyclosporine—psoriasis	0.000224	0.00123	CcSEcCtD
Phenelzine—Hyperhidrosis—Prednisolone—psoriasis	0.000223	0.00123	CcSEcCtD
Phenelzine—Nausea—Hydroxyurea—psoriasis	0.000223	0.00123	CcSEcCtD
Phenelzine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000222	0.00123	CcSEcCtD
Phenelzine—Pruritus—Mycophenolic acid—psoriasis	0.000222	0.00123	CcSEcCtD
Phenelzine—Shock—Hydrocortisone—psoriasis	0.000222	0.00123	CcSEcCtD
Phenelzine—Tachycardia—Hydrocortisone—psoriasis	0.00022	0.00122	CcSEcCtD
Phenelzine—Somnolence—Mycophenolate mofetil—psoriasis	0.00022	0.00122	CcSEcCtD
Phenelzine—Drowsiness—Methotrexate—psoriasis	0.00022	0.00122	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000219	0.00121	CcSEcCtD
Phenelzine—Ill-defined disorder—Betamethasone—psoriasis	0.000219	0.00121	CcSEcCtD
Phenelzine—Ill-defined disorder—Dexamethasone—psoriasis	0.000219	0.00121	CcSEcCtD
Phenelzine—Discomfort—Triamcinolone—psoriasis	0.000219	0.00121	CcSEcCtD
Phenelzine—Fatigue—Cyclosporine—psoriasis	0.000219	0.00121	CcSEcCtD
Phenelzine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000218	0.00121	CcSEcCtD
Phenelzine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000218	0.0012	CcSEcCtD
Phenelzine—Constipation—Cyclosporine—psoriasis	0.000217	0.0012	CcSEcCtD
Phenelzine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000217	0.00387	CbGpPWpGaD
Phenelzine—Dry mouth—Triamcinolone—psoriasis	0.000217	0.0012	CcSEcCtD
Phenelzine—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000215	0.00383	CbGpPWpGaD
Phenelzine—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000214	0.00382	CbGpPWpGaD
Phenelzine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000214	0.00381	CbGpPWpGaD
Phenelzine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000214	0.00118	CcSEcCtD
Phenelzine—Malaise—Dexamethasone—psoriasis	0.000213	0.00118	CcSEcCtD
Phenelzine—Malaise—Betamethasone—psoriasis	0.000213	0.00118	CcSEcCtD
Phenelzine—Oedema—Triamcinolone—psoriasis	0.000212	0.00117	CcSEcCtD
Phenelzine—Constipation—Mycophenolate mofetil—psoriasis	0.000212	0.00117	CcSEcCtD
Phenelzine—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000212	0.00377	CbGpPWpGaD
Phenelzine—Sweating—Methotrexate—psoriasis	0.000211	0.00117	CcSEcCtD
Phenelzine—Feeling abnormal—Cyclosporine—psoriasis	0.000209	0.00116	CcSEcCtD
Phenelzine—Shock—Triamcinolone—psoriasis	0.000209	0.00116	CcSEcCtD
Phenelzine—Insomnia—Prednisolone—psoriasis	0.000209	0.00115	CcSEcCtD
Phenelzine—Dizziness—Mycophenolic acid—psoriasis	0.000208	0.00115	CcSEcCtD
Phenelzine—Paraesthesia—Prednisolone—psoriasis	0.000207	0.00115	CcSEcCtD
Phenelzine—Tachycardia—Triamcinolone—psoriasis	0.000207	0.00115	CcSEcCtD
Phenelzine—Hyperhidrosis—Triamcinolone—psoriasis	0.000205	0.00113	CcSEcCtD
Phenelzine—Convulsion—Betamethasone—psoriasis	0.000205	0.00113	CcSEcCtD
Phenelzine—Convulsion—Dexamethasone—psoriasis	0.000205	0.00113	CcSEcCtD
Phenelzine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000204	0.00113	CcSEcCtD
Phenelzine—Insomnia—Hydrocortisone—psoriasis	0.000204	0.00113	CcSEcCtD
Phenelzine—Paraesthesia—Hydrocortisone—psoriasis	0.000203	0.00112	CcSEcCtD
Phenelzine—Body temperature increased—Cyclosporine—psoriasis	0.000201	0.00111	CcSEcCtD
Phenelzine—Anxiety—Betamethasone—psoriasis	0.0002	0.00111	CcSEcCtD
Phenelzine—Anxiety—Dexamethasone—psoriasis	0.0002	0.00111	CcSEcCtD
Phenelzine—GPT2—Metabolism—CARM1—psoriasis	0.0002	0.00357	CbGpPWpGaD
Phenelzine—Vomiting—Mycophenolic acid—psoriasis	0.0002	0.0011	CcSEcCtD
Phenelzine—Discomfort—Betamethasone—psoriasis	0.000199	0.0011	CcSEcCtD
Phenelzine—Discomfort—Dexamethasone—psoriasis	0.000199	0.0011	CcSEcCtD
Phenelzine—Dyspepsia—Hydrocortisone—psoriasis	0.000199	0.0011	CcSEcCtD
Phenelzine—MAOA—SIDS Susceptibility Pathways—IL13—psoriasis	0.000198	0.00354	CbGpPWpGaD
Phenelzine—Rash—Mycophenolic acid—psoriasis	0.000198	0.00109	CcSEcCtD
Phenelzine—Dermatitis—Mycophenolic acid—psoriasis	0.000198	0.00109	CcSEcCtD
Phenelzine—Headache—Mycophenolic acid—psoriasis	0.000197	0.00109	CcSEcCtD
Phenelzine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000196	0.00108	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000195	0.00108	CcSEcCtD
Phenelzine—Fatigue—Hydrocortisone—psoriasis	0.000195	0.00107	CcSEcCtD
Phenelzine—Vision blurred—Prednisone—psoriasis	0.000194	0.00107	CcSEcCtD
Phenelzine—Oedema—Dexamethasone—psoriasis	0.000193	0.00107	CcSEcCtD
Phenelzine—Oedema—Betamethasone—psoriasis	0.000193	0.00107	CcSEcCtD
Phenelzine—Insomnia—Triamcinolone—psoriasis	0.000192	0.00106	CcSEcCtD
Phenelzine—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000192	0.00342	CbGpPWpGaD
Phenelzine—Ill-defined disorder—Prednisone—psoriasis	0.000191	0.00105	CcSEcCtD
Phenelzine—Paraesthesia—Triamcinolone—psoriasis	0.000191	0.00105	CcSEcCtD
Phenelzine—Feeling abnormal—Prednisolone—psoriasis	0.00019	0.00105	CcSEcCtD
Phenelzine—Shock—Dexamethasone—psoriasis	0.00019	0.00105	CcSEcCtD
Phenelzine—Shock—Betamethasone—psoriasis	0.00019	0.00105	CcSEcCtD
Phenelzine—Agitation—Prednisone—psoriasis	0.000189	0.00104	CcSEcCtD
Phenelzine—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000189	0.00337	CbGpPWpGaD
Phenelzine—Tachycardia—Betamethasone—psoriasis	0.000188	0.00104	CcSEcCtD
Phenelzine—Tachycardia—Dexamethasone—psoriasis	0.000188	0.00104	CcSEcCtD
Phenelzine—Dyspepsia—Triamcinolone—psoriasis	0.000187	0.00103	CcSEcCtD
Phenelzine—Nausea—Mycophenolic acid—psoriasis	0.000186	0.00103	CcSEcCtD
Phenelzine—Hyperhidrosis—Dexamethasone—psoriasis	0.000186	0.00103	CcSEcCtD
Phenelzine—Hyperhidrosis—Betamethasone—psoriasis	0.000186	0.00103	CcSEcCtD
Phenelzine—Feeling abnormal—Hydrocortisone—psoriasis	0.000186	0.00103	CcSEcCtD
Phenelzine—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000186	0.00331	CbGpPWpGaD
Phenelzine—Malaise—Prednisone—psoriasis	0.000186	0.00103	CcSEcCtD
Phenelzine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000185	0.00329	CbGpPWpGaD
Phenelzine—Fatigue—Triamcinolone—psoriasis	0.000183	0.00101	CcSEcCtD
Phenelzine—Asthenia—Cyclosporine—psoriasis	0.000182	0.00101	CcSEcCtD
Phenelzine—Pruritus—Cyclosporine—psoriasis	0.00018	0.000993	CcSEcCtD
Phenelzine—Body temperature increased—Hydrocortisone—psoriasis	0.000178	0.000986	CcSEcCtD
Phenelzine—Convulsion—Prednisone—psoriasis	0.000178	0.000985	CcSEcCtD
Phenelzine—Asthenia—Mycophenolate mofetil—psoriasis	0.000178	0.000982	CcSEcCtD
Phenelzine—Pruritus—Mycophenolate mofetil—psoriasis	0.000175	0.000968	CcSEcCtD
Phenelzine—Feeling abnormal—Triamcinolone—psoriasis	0.000175	0.000967	CcSEcCtD
Phenelzine—Anxiety—Prednisone—psoriasis	0.000175	0.000964	CcSEcCtD
Phenelzine—Insomnia—Dexamethasone—psoriasis	0.000174	0.000963	CcSEcCtD
Phenelzine—Insomnia—Betamethasone—psoriasis	0.000174	0.000963	CcSEcCtD
Phenelzine—Paraesthesia—Betamethasone—psoriasis	0.000173	0.000957	CcSEcCtD
Phenelzine—Paraesthesia—Dexamethasone—psoriasis	0.000173	0.000957	CcSEcCtD
Phenelzine—Discomfort—Prednisone—psoriasis	0.000173	0.000956	CcSEcCtD
Phenelzine—CYP3A43—Metabolism—NDUFA5—psoriasis	0.000171	0.00305	CbGpPWpGaD
Phenelzine—Dyspepsia—Dexamethasone—psoriasis	0.00017	0.000938	CcSEcCtD
Phenelzine—Dyspepsia—Betamethasone—psoriasis	0.00017	0.000938	CcSEcCtD
Phenelzine—Body temperature increased—Triamcinolone—psoriasis	0.000168	0.000928	CcSEcCtD
Phenelzine—Dizziness—Cyclosporine—psoriasis	0.000168	0.000928	CcSEcCtD
Phenelzine—Oedema—Prednisone—psoriasis	0.000168	0.000928	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000166	0.00092	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000166	0.00092	CcSEcCtD
Phenelzine—Fatigue—Betamethasone—psoriasis	0.000166	0.000918	CcSEcCtD
Phenelzine—Fatigue—Dexamethasone—psoriasis	0.000166	0.000918	CcSEcCtD
Phenelzine—Shock—Prednisone—psoriasis	0.000165	0.000913	CcSEcCtD
Phenelzine—Tachycardia—Prednisone—psoriasis	0.000164	0.000905	CcSEcCtD
Phenelzine—Dizziness—Mycophenolate mofetil—psoriasis	0.000164	0.000905	CcSEcCtD
Phenelzine—GPT—Metabolism—CARM1—psoriasis	0.000163	0.00291	CbGpPWpGaD
Phenelzine—Hyperhidrosis—Prednisone—psoriasis	0.000162	0.000897	CcSEcCtD
Phenelzine—Vision blurred—Methotrexate—psoriasis	0.000162	0.000895	CcSEcCtD
Phenelzine—Asthenia—Hydrocortisone—psoriasis	0.000162	0.000895	CcSEcCtD
Phenelzine—Vomiting—Cyclosporine—psoriasis	0.000161	0.000892	CcSEcCtD
Phenelzine—Rash—Cyclosporine—psoriasis	0.00016	0.000885	CcSEcCtD
Phenelzine—Dermatitis—Cyclosporine—psoriasis	0.00016	0.000884	CcSEcCtD
Phenelzine—Pruritus—Hydrocortisone—psoriasis	0.00016	0.000882	CcSEcCtD
Phenelzine—Ill-defined disorder—Methotrexate—psoriasis	0.00016	0.000881	CcSEcCtD
Phenelzine—Headache—Cyclosporine—psoriasis	0.000159	0.000879	CcSEcCtD
Phenelzine—Feeling abnormal—Dexamethasone—psoriasis	0.000159	0.000878	CcSEcCtD
Phenelzine—Feeling abnormal—Betamethasone—psoriasis	0.000159	0.000878	CcSEcCtD
Phenelzine—Vomiting—Mycophenolate mofetil—psoriasis	0.000157	0.00087	CcSEcCtD
Phenelzine—Rash—Mycophenolate mofetil—psoriasis	0.000156	0.000863	CcSEcCtD
Phenelzine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000156	0.000862	CcSEcCtD
Phenelzine—Headache—Mycophenolate mofetil—psoriasis	0.000155	0.000857	CcSEcCtD
Phenelzine—Malaise—Methotrexate—psoriasis	0.000155	0.000857	CcSEcCtD
Phenelzine—Leukopenia—Methotrexate—psoriasis	0.000154	0.00085	CcSEcCtD
Phenelzine—Dizziness—Prednisolone—psoriasis	0.000153	0.000844	CcSEcCtD
Phenelzine—Asthenia—Triamcinolone—psoriasis	0.000152	0.000842	CcSEcCtD
Phenelzine—Body temperature increased—Dexamethasone—psoriasis	0.000152	0.000842	CcSEcCtD
Phenelzine—Body temperature increased—Betamethasone—psoriasis	0.000152	0.000842	CcSEcCtD
Phenelzine—Insomnia—Prednisone—psoriasis	0.000152	0.000839	CcSEcCtD
Phenelzine—Nausea—Cyclosporine—psoriasis	0.000151	0.000833	CcSEcCtD
Phenelzine—Paraesthesia—Prednisone—psoriasis	0.000151	0.000833	CcSEcCtD
Phenelzine—Pruritus—Triamcinolone—psoriasis	0.00015	0.000831	CcSEcCtD
Phenelzine—Dizziness—Hydrocortisone—psoriasis	0.000149	0.000825	CcSEcCtD
Phenelzine—Convulsion—Methotrexate—psoriasis	0.000149	0.000823	CcSEcCtD
Phenelzine—Dyspepsia—Prednisone—psoriasis	0.000148	0.000817	CcSEcCtD
Phenelzine—Nausea—Mycophenolate mofetil—psoriasis	0.000147	0.000813	CcSEcCtD
Phenelzine—Rash—Prednisolone—psoriasis	0.000146	0.000805	CcSEcCtD
Phenelzine—CYP3A43—Metabolism—CYP2S1—psoriasis	0.000146	0.0026	CbGpPWpGaD
Phenelzine—Dermatitis—Prednisolone—psoriasis	0.000146	0.000804	CcSEcCtD
Phenelzine—Fatigue—Prednisone—psoriasis	0.000145	0.0008	CcSEcCtD
Phenelzine—Headache—Prednisolone—psoriasis	0.000145	0.0008	CcSEcCtD
Phenelzine—Discomfort—Methotrexate—psoriasis	0.000145	0.000799	CcSEcCtD
Phenelzine—Constipation—Prednisone—psoriasis	0.000144	0.000793	CcSEcCtD
Phenelzine—Vomiting—Hydrocortisone—psoriasis	0.000143	0.000793	CcSEcCtD
Phenelzine—Rash—Hydrocortisone—psoriasis	0.000142	0.000786	CcSEcCtD
Phenelzine—Dermatitis—Hydrocortisone—psoriasis	0.000142	0.000785	CcSEcCtD
Phenelzine—Headache—Hydrocortisone—psoriasis	0.000141	0.000781	CcSEcCtD
Phenelzine—Dizziness—Triamcinolone—psoriasis	0.000141	0.000776	CcSEcCtD
Phenelzine—Feeling abnormal—Prednisone—psoriasis	0.000138	0.000764	CcSEcCtD
Phenelzine—Asthenia—Dexamethasone—psoriasis	0.000138	0.000764	CcSEcCtD
Phenelzine—Asthenia—Betamethasone—psoriasis	0.000138	0.000764	CcSEcCtD
Phenelzine—Nausea—Prednisolone—psoriasis	0.000137	0.000758	CcSEcCtD
Phenelzine—Pruritus—Dexamethasone—psoriasis	0.000136	0.000754	CcSEcCtD
Phenelzine—Pruritus—Betamethasone—psoriasis	0.000136	0.000754	CcSEcCtD
Phenelzine—Hyperhidrosis—Methotrexate—psoriasis	0.000136	0.00075	CcSEcCtD
Phenelzine—Vomiting—Triamcinolone—psoriasis	0.000135	0.000746	CcSEcCtD
Phenelzine—Nausea—Hydrocortisone—psoriasis	0.000134	0.000741	CcSEcCtD
Phenelzine—Rash—Triamcinolone—psoriasis	0.000134	0.00074	CcSEcCtD
Phenelzine—Dermatitis—Triamcinolone—psoriasis	0.000134	0.00074	CcSEcCtD
Phenelzine—Headache—Triamcinolone—psoriasis	0.000133	0.000735	CcSEcCtD
Phenelzine—Body temperature increased—Prednisone—psoriasis	0.000133	0.000733	CcSEcCtD
Phenelzine—MAOB—Metabolism—NDUFA5—psoriasis	0.00013	0.00231	CbGpPWpGaD
Phenelzine—Dizziness—Betamethasone—psoriasis	0.000127	0.000704	CcSEcCtD
Phenelzine—Dizziness—Dexamethasone—psoriasis	0.000127	0.000704	CcSEcCtD
Phenelzine—Insomnia—Methotrexate—psoriasis	0.000127	0.000701	CcSEcCtD
Phenelzine—Nausea—Triamcinolone—psoriasis	0.000126	0.000697	CcSEcCtD
Phenelzine—Paraesthesia—Methotrexate—psoriasis	0.000126	0.000696	CcSEcCtD
Phenelzine—Somnolence—Methotrexate—psoriasis	0.000125	0.000689	CcSEcCtD
Phenelzine—MAOA—SIDS Susceptibility Pathways—IL10—psoriasis	0.000124	0.00221	CbGpPWpGaD
Phenelzine—Dyspepsia—Methotrexate—psoriasis	0.000124	0.000682	CcSEcCtD
Phenelzine—GPT2—Metabolism—CAT—psoriasis	0.000123	0.0022	CbGpPWpGaD
Phenelzine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000123	0.00219	CbGpPWpGaD
Phenelzine—Vomiting—Dexamethasone—psoriasis	0.000123	0.000677	CcSEcCtD
Phenelzine—Vomiting—Betamethasone—psoriasis	0.000123	0.000677	CcSEcCtD
Phenelzine—Rash—Dexamethasone—psoriasis	0.000122	0.000672	CcSEcCtD
Phenelzine—Rash—Betamethasone—psoriasis	0.000122	0.000672	CcSEcCtD
Phenelzine—Dermatitis—Dexamethasone—psoriasis	0.000121	0.000671	CcSEcCtD
Phenelzine—Dermatitis—Betamethasone—psoriasis	0.000121	0.000671	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000121	0.000669	CcSEcCtD
Phenelzine—Fatigue—Methotrexate—psoriasis	0.000121	0.000668	CcSEcCtD
Phenelzine—Headache—Dexamethasone—psoriasis	0.000121	0.000667	CcSEcCtD
Phenelzine—Headache—Betamethasone—psoriasis	0.000121	0.000667	CcSEcCtD
Phenelzine—Asthenia—Prednisone—psoriasis	0.00012	0.000666	CcSEcCtD
Phenelzine—Pruritus—Prednisone—psoriasis	0.000119	0.000656	CcSEcCtD
Phenelzine—Feeling abnormal—Methotrexate—psoriasis	0.000116	0.000639	CcSEcCtD
Phenelzine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000115	0.00205	CbGpPWpGaD
Phenelzine—Nausea—Betamethasone—psoriasis	0.000115	0.000633	CcSEcCtD
Phenelzine—Nausea—Dexamethasone—psoriasis	0.000115	0.000633	CcSEcCtD
Phenelzine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000114	0.00203	CbGpPWpGaD
Phenelzine—Dizziness—Prednisone—psoriasis	0.000111	0.000613	CcSEcCtD
Phenelzine—Body temperature increased—Methotrexate—psoriasis	0.000111	0.000613	CcSEcCtD
Phenelzine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.00011	0.00197	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—CYP2S1—psoriasis	0.00011	0.00197	CbGpPWpGaD
Phenelzine—Vomiting—Prednisone—psoriasis	0.000107	0.00059	CcSEcCtD
Phenelzine—Rash—Prednisone—psoriasis	0.000106	0.000585	CcSEcCtD
Phenelzine—Dermatitis—Prednisone—psoriasis	0.000106	0.000584	CcSEcCtD
Phenelzine—Headache—Prednisone—psoriasis	0.000105	0.000581	CcSEcCtD
Phenelzine—Asthenia—Methotrexate—psoriasis	0.000101	0.000556	CcSEcCtD
Phenelzine—GPT—Metabolism—CAT—psoriasis	0.0001	0.00179	CbGpPWpGaD
Phenelzine—Nausea—Prednisone—psoriasis	9.97e-05	0.000551	CcSEcCtD
Phenelzine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	9.94e-05	0.00177	CbGpPWpGaD
Phenelzine—Pruritus—Methotrexate—psoriasis	9.93e-05	0.000549	CcSEcCtD
Phenelzine—GPT2—Metabolism—APOE—psoriasis	9.58e-05	0.00171	CbGpPWpGaD
Phenelzine—Dizziness—Methotrexate—psoriasis	9.28e-05	0.000513	CcSEcCtD
Phenelzine—Vomiting—Methotrexate—psoriasis	8.92e-05	0.000493	CcSEcCtD
Phenelzine—Rash—Methotrexate—psoriasis	8.85e-05	0.000489	CcSEcCtD
Phenelzine—Dermatitis—Methotrexate—psoriasis	8.84e-05	0.000488	CcSEcCtD
Phenelzine—Headache—Methotrexate—psoriasis	8.79e-05	0.000486	CcSEcCtD
Phenelzine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.57e-05	0.00153	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—PPARG—psoriasis	8.34e-05	0.00149	CbGpPWpGaD
Phenelzine—Nausea—Methotrexate—psoriasis	8.33e-05	0.000461	CcSEcCtD
Phenelzine—MAOA—Metabolism—NDUFA5—psoriasis	8.14e-05	0.00145	CbGpPWpGaD
Phenelzine—GPT—Metabolism—APOE—psoriasis	7.81e-05	0.00139	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—CARM1—psoriasis	7.11e-05	0.00127	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—CYP2S1—psoriasis	6.92e-05	0.00123	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—NDUFA5—psoriasis	6.9e-05	0.00123	CbGpPWpGaD
Phenelzine—GPT—Metabolism—PPARG—psoriasis	6.8e-05	0.00121	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—CXCL8—psoriasis	6.79e-05	0.00121	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—JUN—psoriasis	6.31e-05	0.00113	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—NFKB1—psoriasis	6.08e-05	0.00108	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—CYP2S1—psoriasis	5.86e-05	0.00105	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—VEGFA—psoriasis	5.51e-05	0.000983	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—CARM1—psoriasis	5.39e-05	0.00096	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—NDUFA5—psoriasis	5e-05	0.00089	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—NDUFA5—psoriasis	4.99e-05	0.000889	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—TNF—psoriasis	4.73e-05	0.000842	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—CAT—psoriasis	4.37e-05	0.00078	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—NDUFA5—psoriasis	4.32e-05	0.00077	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—CYP2S1—psoriasis	4.25e-05	0.000757	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—CYP2S1—psoriasis	4.24e-05	0.000756	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.03e-05	0.000718	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—NDUFA5—psoriasis	3.85e-05	0.000687	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—IL6—psoriasis	3.81e-05	0.00068	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—CYP2S1—psoriasis	3.67e-05	0.000654	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.59e-05	0.000641	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—APOE—psoriasis	3.4e-05	0.000606	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—CARM1—psoriasis	3.38e-05	0.000603	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—CAT—psoriasis	3.31e-05	0.000591	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—CYP2S1—psoriasis	3.28e-05	0.000584	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—PPARG—psoriasis	2.96e-05	0.000528	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—CARM1—psoriasis	2.86e-05	0.00051	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—APOE—psoriasis	2.58e-05	0.000459	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—NDUFA5—psoriasis	2.32e-05	0.000413	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—PPARG—psoriasis	2.24e-05	0.0004	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—CAT—psoriasis	2.08e-05	0.000371	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—CARM1—psoriasis	2.07e-05	0.00037	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—CARM1—psoriasis	2.07e-05	0.000369	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.97e-05	0.000351	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.92e-05	0.000343	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—CARM1—psoriasis	1.79e-05	0.00032	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—CAT—psoriasis	1.76e-05	0.000314	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.72e-05	0.000306	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.68e-05	0.000299	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—APOE—psoriasis	1.62e-05	0.000288	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—CARM1—psoriasis	1.6e-05	0.000285	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.5e-05	0.000267	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—PPARG—psoriasis	1.41e-05	0.000251	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—APOE—psoriasis	1.37e-05	0.000244	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—CAT—psoriasis	1.28e-05	0.000227	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—CAT—psoriasis	1.27e-05	0.000227	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—PPARG—psoriasis	1.19e-05	0.000212	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—CAT—psoriasis	1.1e-05	0.000197	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—APOE—psoriasis	9.91e-06	0.000177	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—APOE—psoriasis	9.89e-06	0.000176	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—CAT—psoriasis	9.84e-06	0.000175	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—CARM1—psoriasis	9.62e-06	0.000172	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—PPARG—psoriasis	8.64e-06	0.000154	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—PPARG—psoriasis	8.62e-06	0.000154	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—APOE—psoriasis	8.57e-06	0.000153	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—APOE—psoriasis	7.65e-06	0.000136	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—PPARG—psoriasis	7.46e-06	0.000133	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—PPARG—psoriasis	6.66e-06	0.000119	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—CAT—psoriasis	5.92e-06	0.000106	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—APOE—psoriasis	4.6e-06	8.2e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—PPARG—psoriasis	4.01e-06	7.14e-05	CbGpPWpGaD
